药物对比
Pioglitazone vs Vildagliptin
比较 Pioglitazone 与 Vildagliptin 治疗2型糖尿病。TZD 与 DPP-4抑制剂：疗效、心力衰竭风险、体重影响及安全性特征。
此页面暂无可用的对比维度。
临床背景
This comparison arises when selecting second-line oral antidiabetic therapy for type 2 diabetes patients, especially those with insulin resistance or cardiovascular considerations.
结论
Neither drug is universally superior; Pioglitazone provides stronger insulin sensitization at the cost of significant risks, while Vildagliptin offers safer, modest glycemic control.
全部药物对比